Ceftiofur Sodium CAS 104010-37-9 Factory Supply

Product name: Ceftiofur Sodium

Other name: Ceftiofur sodium salt; Sodium ceftiofur; (6R-(6alpha,7beta(Z))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((2-furanylcarbonyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt;CCRIS 7601; Naxcel; Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(mercaptomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 2-furoate (ester);

MF: C19H18N5NaO7S3

MW: 547.55

CAS: 104010-37-9

EINECS: 680-655-2

Prompt shipment

FOB Wuhan

Wuhan port sails

Inquire Now

Application: Pharmacy

Learn more for Application

Properties:

Appearance: light yellow solid. Density: 1.81 g/cm3.

Brief introduction:

Ceftiofur Sodium is a special antibiotic for cephalosporins in veterinary clinic. It has strong antibacterial effect on gram-positive bacteria and gram-negative bacteria. Cefotirome acts on transcriptpeptidase and blocks the synthesis of mucin, which causes bacterial cell wall loss and sterilization. Ceftiodom has a stable β -lactam ring, which is not easily destroyed by drug-resistant bacteria and can act on both gram-positive and gram-negative bacteria producing β -lactam enzyme.

Usage:

Mainly used for severe bacterial infection and poultry escherichia coli, salmonella.

1. Virus, bacteria systemic or local infection caused by high temperature and high fever, cough, gasping, dyspnea, red skin purple, purple roots of the ears, mouth and feet ulceration, abortion and stillbirth, revolving, hind limb paralysis, do not eat, lying on the ground, constipation and diarrhea.

2. Infectious pleurisy, Actinobacillus, Pasteurella multocida, Streptococcus mutans, piglet yellow white dysentery, Salmonella, Haemophilus parathyophilus, atrophic rhinitis, chlamydia, etc.

3. Livestock prenatal and postnatal high fever, endometritis, mastitis, no milk and little milk syndrome, hoof inflammation, hoof rot, cattle and sheep Pasteurella, transport fever, pneumonia, nasal atrophy, etc.

Application

Pharmaceutical intermediates